Detalles de la búsqueda
1.
Impacts of endocrine-disrupting chemicals on prostate function and cancer.
Environ Res;
204(Pt B): 112085, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34562481
2.
The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression.
J Clin Invest;
2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38625747
3.
Estrogens and endocrine-disrupting chemicals differentially impact the bioenergetic fluxes of mammary epithelial cells in two- and three-dimensional models.
Environ Int;
179: 108132, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37657410
4.
Role of Secreted Frizzled-Related Protein 1 in Early Breast Carcinogenesis and Breast Cancer Aggressiveness.
Cancers (Basel);
15(8)2023 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37190179
5.
Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.
Mol Oncol;
17(10): 2109-2125, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37086156
6.
FACS-Free isolation and purification protocol of mouse prostate epithelial cells for organoid primary culture.
MethodsX;
9: 101843, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36147450
7.
Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion.
Mol Metab;
62: 101516, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35598879
8.
A FACS-Free Purification Method to Study Estrogen Signaling, Organoid Formation, and Metabolic Reprogramming in Mammary Epithelial Cells.
Front Endocrinol (Lausanne);
12: 672466, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34456857
9.
Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.
JCI Insight;
5(15)2020 08 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32759499
Resultados
1 -
9
de 9
1
Próxima >
>>